Enteric nervous system

The enteric nervous system (ENS) derives from the neural crest and consists of neurons distributed in two ganglionated plexuses, myenteric and submucosal, located within the walls of the gut. The ENS contains as many neurons as the spinal cord (approximately 80-100 million neurons) and controls intestinal motility and secretion largely independently of influences from the CNS.1–5 The ENS is affected by Lewy body pathology at early stages of PD,6,7 and by many genetic8,9 or immune9,10 neurologic disorders associated with gastrointestinal dysmotility. The aim of this paper is to briefly review the functional and neurochemical organization of the ENS and its involvement in neurologic disorders. There are recent comprehensive reviews on these subjects.3,8,9,11,12 The control of motility and secretion in the gastrointestinal tract depends on both extrinsic parasympathetic and sympathetic innervation and intrinsic innervation, provided by the ENS. Extrinsic parasympathetic inputs originate in the dorsal motor nucleus of the vagus, which controls primarily the motility of the esophagus and stomach, and the sacral parasympathetic nucleus, which contributes to control of motility of the distal colon and rectum. The prevertebral sympathetic ganglia mediate peripheral reflexes that inhibit motility of the gut. The intrinsic innervation of the gut consists of the ganglia of the ENS, which are grouped into two plexuses: the myenteric plexus (of Auerbach), located between the outer longitudinal and the inner circular muscle layers, and submucosal plexus (of Meissner), located between the circular muscle and the muscularis mucosae (figure).1–4 The ENS controls intestinal motility and secretion largely independently of extrinsic parasympathetic and sympathetic innervation, although these extrinsic influences have a modulatory role on ENS activity. Neurons of the myenteric plexus control the activity of the smooth muscle of the gut whereas those in the submucosal plexus also regulate mucosal secretion and blood flow. …

[1]  M. Camilleri,et al.  Human enteric neuropathies: morphology and molecular pathology , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[2]  M. Valentino,et al.  Thymidine phosphorylase mutations cause instability of mitochondrial DNA. , 2005, Gene.

[3]  P. Wade,et al.  Enteric nervous system , 1993 .

[4]  Hitoshi Takahashi,et al.  Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system , 2004, Acta Neuropathologica.

[5]  S. Takeda,et al.  Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. , 1993, Advances in neurology.

[6]  J. Tack,et al.  REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders , 2007 .

[7]  G. Farrugia,et al.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. , 2000, The New England journal of medicine.

[8]  E. Pagnotta,et al.  Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. , 2003, Gastroenterology.

[9]  J. Moreau,et al.  Thymoma-Associated Neuromyotonia with Antibodies against Voltage-Gated Potassium Channels Presenting as Chronic Intestinal Pseudo-Obstruction , 2005, European Neurology.

[10]  M. Schwartz,et al.  Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. , 2007, Archives of neurology.

[11]  H. Parkman,et al.  Effects of clonidine and tricyclic antidepressants on gastric smooth muscle contractility , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[12]  Kevin Lee,et al.  5-HT in the enteric nervous system: gut function and neuropharmacology , 2007, Trends in Neurosciences.

[13]  V. Lennon,et al.  Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. , 2006, Gastroenterology.

[14]  M. McAlindon,et al.  Familial visceral neuropathy: A defined entity? , 2005, American journal of medical genetics. Part A.

[15]  H. Braak,et al.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered , 2006, Movement disorders : official journal of the Movement Disorder Society.

[16]  P. Tonali,et al.  Chronic autoimmune autonomic neuropathy responsive to immunosuppressive therapy , 2007, Neurology.

[17]  M. Gershon,et al.  Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2 Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice , 2006, The Journal of Neuroscience.

[18]  S. Brookes,et al.  Anatomy and physiology of the enteric nervous system , 2000, Gut.

[19]  J. Furness.  Types of neurons in the enteric nervous system. , 2000, Journal of the autonomic nervous system.

[20]  A. Lipp,et al.  Plasma exchange for primary autoimmune autonomic failure. , 2005, The New England journal of medicine.

[21]  M. Anlauf,et al.  Chemical coding of the human gastrointestinal nervous system: Cholinergic, VIPergic, and catecholaminergic phenotypes , 2003, The Journal of comparative neurology.

[22]  Q. Al-Saleh,et al.  Allgrove syndrome with features of familial dysautonomia: A novel mutation in the AAAS gene , 2006, Acta paediatrica.

[23]  H. Braak,et al.  Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.

[24]  R. Pfeiffer,et al.  Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation , 1995, The Lancet.

[25]  A. Huebner,et al.  Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - shedding light on an unexpected splice mutation. , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[26]  D. Lacombe,et al.  Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutation. , 2002, Neurology.

[27]  G. Barbara,et al.  New insights into human enteric neuropathies , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[28]  J. Dalmau,et al.  Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. , 1991, Gastroenterology.

[29]  A. Rühl.  Glial cells in the gut , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.